Alto contenido de ácido linoleico conjugado (CLA) en leche y productos derivados al incorporar semillas de girasol a la dieta vacuna: implicaciones sobre el riesgo trombo/aterogénico / High conjugated linoleic acid (CLA) content in milk and dairy products using a dietary supplementation of sunflower seed in cows: thrombogenic/atherogenic risk issues

Con la finalidad de determinar el perfil de ácidos grasos y la composición química de productos lácteos enriquecidos con ácido linoleico conjugado (CLA) de manera natural, se elaboraron crema, mantequilla y grasa butírica con leche obtenida de vacas que recibieron una dieta control o suplementación con semilla de girasol en un 11.2%. El análisis químico incluyó el perfil de ácidos grasos,materia grasa, proteína y cenizas; en la leche se determinó además el contenido de lactosa. Se calcularon los índices de aterogenicidad (IA) y trombogenicidad (IT) en la leche y productos elaborados. Los resultados indicaron que los contenidos de grasa, proteína, lactosa y ceniza no fueron afectados por la incorporación de semilla de girasol en la dieta de los animales. El contenido promedio de CLA y ácidotrans vaccénico (TVA) expresados en g/100 g de lípidos totales fue, para los productos control, 0.54 y 1.6; mientras que para los productos ricos en CLA fueron 2 y 6.4, lo cual representa un incremento de cuatro veces. Además, en los productos ricos en CLA los IA e IT disminuyeron considerablemente (38.4 y 25% menos, respectivamente). Se observó que los perfiles de ácidos grasos no se modificaron durante el procesamiento, indicando que el CLA es un componente estable en los productos lácteos analizados. El uso de semilla de girasol en la dieta de las vacas, incrementa el contenido de CLA y TVA en los productos lácteos y disminuye el riesgo de enfermedades cardiovasculares en humanos sin afectar la proporción de los componentes mayoritarios.

High conjugated linoleic acid (CLA) content in milk and dairy products using a dietary supplementation of sunflower seed in cows. Thrombogenic/atherogenic risk issues. This studywas undertaken to determine the effect of dietary supplementation of sunflower seed in cows on the chemical composition of milk and dairy products. Cream, butter and butter oil were prepared from milk produced by cows fed a control diet (control products) or diet supplemented with 11.2% sunflour seed (CLA-rich products). Milk samples collected were determined for lactose. A sample of CLArich or control product was determined for fatty acid profile as well as fat, protein and ash contents. The index of atherogenicity (IA) and the index of thrombogenicity (IT) were also calculated. Results revealed that there was no effect of the inclusion of sunflower seed in the diet on the lactose content in milk and total fat, protein and ash contents in the dairy products. Average contents of conjugated linoleic acid (CLA) and transvaccenic acid (TVA), expressed as g/ 100g total fatty acid were 0.54 and 1.6, respectively in the control products, and 2 and 6.4, respectively in the CLA-rich products. The content of either CLA or TVA was approximately four fold higher in the latter products. Moreover, CLA-rich products showed considerably low IA and IT, which were, respectively, 38.4 and 25.0% less than those from control products. Fatty acid profiles were unaffected during processing, which demonstrates that CLA is a stable component in the dairy products analyzed. It was concluded that dietary supplementation of sunflower seed in cows increases the CLA and TVA contents in milk, which may contribute to the reduction of the risk of cardiovascular diseases in humans.

[Review: functional foods and ingredients derived from milk]. / Revisión: Alimentos e ingredientes funcionales derivados de la leche.

The objective of this paper is to review the main research works related to functional foods and ingredients derived from milk. Research in functional foods has increased during last twelve years with the intention of increasing life expectancy and improving human health conditions. Probiotics, prebiotics, bioactive peptides or proteins, dietetic fibers and fatty acids, as well as the addition of fitochemical compounds in dairy products and a record of some allergic compounds are also discussed. The demand of this kind of products is increasing due to intense advertising campaigns posted in many countries. Basically, these campaigns promise better health and/or the prevention of certain illnesses. Milk contains diverse constituents with physiological functionality, which might change the traditional view point that we have about drugs. The topic of functional foods in general, and specifically that from milk and dairy products, has still not been completely exploited, and in the future it will be found that the best work has not been carried out in this area.

Purification of kappa-casien glycomacropeptide from sweet whey with undetectable level of phenylalanine.

Glycomacropeptide (GMP) found in sweet whey is a biologically active compound released from kappa-casein by the action of chymosin during cheese making. This study was undertaken to purify GMP from sweet whey as a research chemical on a laboratory scale. Glycomacropeptide was isolated from proteins and other non-GMP compounds by deproteinization with trichloroacetic acid and gel chromatography on Sephacryl S-200. The purified GMP accounted for 0.12% of dry sweet whey powder and contained 107.0, 50.9, 61.2 and 4.3 microg, respectively, of sialic acid, galactose, galactosamine and phosphorus per mg dry weight. The GMP was of high purity, with its amino acid composition showing undetectable levels of phenylalanine, tyrosine and arginine, the amino acids that do not occur in bovine GMP. On gel electrophoresis, the GMP showed a single broad band with an average mobility faster than that of carbonic anhydrase (molecular weight = 31 kDa). The purified GMP may be used as a standard glycopeptide in chromatography and electrophoresis and may also be used to test various known or unknown properties and biological activities of this compound.

Isolation and analysis of kappa-casein glycomacropeptide from goat sweet whey.

Glycomacropeptide (GMP) was purified from goat sweet whey by anion-exchange and hydrophobic interaction chromatography. Approximately 0.06% (w/v) of sweet whey was recovered as GMP. Amino acid analysis of the GMP preparation showed that the content of phenylalanine (an amino acid that does not occur in goat GMP) was negligible, indicating that the GMP was of high purity. The goat GMP contained 25 microg sialic acid per mg of dry weight. This was approximately 3-fold lower than the sialic acid concentration in bovine GMP reported in the literature. Gel electrophoretic results demonstrated that most of the goat GMP occurs as a dimer. The GMP was intensely stained with Coomassie blue in 50% methanol containing 12.5% (w/v) trichloroacetic acid, but showed very weak metachromasia with the same dye in 45% methanol containing 10% acetic acid, a preparation commonly used to stain protein.